Acrivon Therapeutics, Inc. (ACRV)

NASDAQ: ACRV · Real-Time Price · USD

1.640

-0.020 (-1.20%)

At close: Mar 18, 2026, 4:00 PM EDT

1.640

0.00 (0.00%)

After-hours: Mar 18, 2026, 4:10 PM EDT

Acrivon Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	35.41	39.82	36.02	29.52	99.6	1.58
Short-Term Investments	93.85	139.66	91.44	98.23	-	-
Cash & Short-Term Investments	129.25	179.48	127.46	127.75	99.6	1.58
Cash Growth	-31.05%	40.81%	-0.23%	28.26%	6192.04%	-
Other Current Assets	1.11	2.15	2.23	4.34	0.81	0.14
Total Current Assets	130.36	181.63	129.69	132.1	100.41	1.72
Net Property, Plant & Equipment	7.98	8.03	7.91	6.86	5.79	0.06
Long-Term Investments	5.11	5.09	-	41.88	-	-
Other Long-Term Assets	1.85	1.85	0.67	0.39	0.39	0.41
Total Assets	145.3	196.59	138.27	181.23	106.59	2.19
Accounts Payable	1	0.76	5.05	0.9	0.96	0.14
Accrued Expenses	12.71	15.4	7.38	4.89	1.29	0.48
Current Portion of Leases	1.18	1.06	0.88	0.73	0.66	-
Total Current Liabilities	14.89	17.21	13.3	6.52	2.91	0.61
Long-Term Leases	1.81	2.59	3.77	4.24	4.96	-
Total Long-Term Liabilities	1.81	2.59	3.77	4.24	4.96	-
Total Liabilities	16.7	19.8	17.07	10.75	7.88	0.93
Common Stock	0.03	0.03	0.02	0.02	0	0
Additional Paid-in Capital	384.36	373.28	237.68	226.58	1.05	0.21
Accumulated Other Comprehensive Income	0.11	0.45	-0.08	-0.1	-	-
Retained Earnings	-255.9	-196.98	-116.42	-56.03	-24.87	-8.62
Total Common Shareholders' Equity	128.6	176.79	121.2	170.48	-23.81	-8.41
Minority Interest	-	-	-	-	122.52	9.99
Shareholders' Equity	128.6	176.79	121.2	170.48	98.71	1.57
Total Liabilities & Equity	145.3	196.59	138.27	181.23	106.59	2.19
Total Debt	2.99	3.65	4.64	4.96	5.63	0
Net Cash (Debt)	126.27	175.84	122.81	122.79	93.98	1.58
Net Cash Growth	-28.19%	43.17%	0.02%	30.66%	5836.51%	-
Net Cash Per Share	3.29	5.20	5.56	29.79	53.90	-
Book Value	128.6	176.79	121.2	170.48	-23.81	-8.41
Book Value Per Share	3.35	5.23	5.49	41.36	-13.66	-
Tangible Book Value	128.6	176.79	121.2	170.48	-23.81	-8.41
Tangible Book Value Per Share	3.35	5.23	5.49	41.36	-13.66	-

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q